Prognostic value of left atrium remodeling after primary percutaneous coronary intervention in patients with ST

Jang Hyun Cho1, Su Hyun Kim, Cheol hwan Kim

  • 1Division of Cardiology, Department of Internal Medicine, St. Carollo Hospital, Suncheon, Korea.

Insights

Changes in left atrial size after acute myocardial infarction (AMI) predict future cardiac events. Monitoring left atrial volume index (LAVI) post-AMI offers crucial prognostic insights beyond traditional markers.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiac Imaging

Background:

  • Left atrial (LA) size is a recognized indicator of cardiovascular health.
  • Acute myocardial infarction (AMI) significantly impacts cardiac remodeling and function.
  • Long-term prognostic markers following percutaneous coronary intervention (PCI) are crucial for patient management.

Purpose of the Study:

  • To investigate the association between left atrial (LA) size and patient outcomes after acute myocardial infarction (AMI) treated with primary percutaneous coronary intervention (PCI).
  • To evaluate the dynamic changes in LA size during long-term follow-up after AMI.
  • To determine if changes in LA volume index (LAVI) predict adverse cardiac events.

Main Methods:

  • Echocardiographic analysis of 253 AMI patients undergoing primary PCI.
  • Measurement of left atrial volume index (LAVI) at baseline (AMI onset) and at 12 months.
  • Clinical follow-up for an average of 30.8 months.

Main Results:

  • A change in LAVI independently predicted new-onset atrial fibrillation or hospitalization for heart failure (P = 0.002).
  • Patients surviving 12 months showed a significant increase in mean LAVI (26.1 to 28.0 mL/m², P < 0.001).
  • Increased LAVI correlated with reduced left ventricular ejection fraction, larger ventricular dimensions, and enlarged LA size.

Conclusions:

  • Changes in LAVI serve as a valuable parameter for predicting subsequent adverse cardiac events in AMI patients.
  • Post-AMI echocardiographic assessment of LAVI provides prognostic information superior to clinical and laboratory parameters alone.
  • Dynamic monitoring of LA size offers critical insights into long-term outcomes after AMI.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...